Skip to main content

Abeona Therapeutics Inc.

ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000318306

In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Abeona Therapeutics Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ABEO: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders6053−7
Shares25.2M40.9M+15.7M (+62.2%)
Value$28.3M$13.7M−$14.6M (−51.6%)

New holders (12)

Institutions that held Abeona Therapeutics Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ABEO in Q4 2021
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.3,200,000$1.08M0.00%
D. E. Shaw & Co., Inc.2,518,655$849.0K0.00%
Worth Venture Partners, LLC1,137,274$383.0K0.19%
AIGH Capital Management LLC1,137,274$383.0K0.12%
Citadel Advisors LLC332,712$112.0K0.00%
Virtu Financial LLC250,637$84.0K0.01%
Acadian Asset Management LLC236,681$78.0K0.00%
Shay Capital LLC50,000$17.0K0.01%
Two Sigma Advisers, LP31,400$11.0K0.00%
Warberg Asset Management LLC23,200$8.00K0.00%
Susquehanna International Group, LLP11,176$4.00K0.00%
Squarepoint Ops LLC12,265$4.00K0.00%

Sold out (19)

Institutions that held Abeona Therapeutics Inc. at the end of Q3 2021 and filed for Q4 2021 without it.